Clinical Trials Browser

Phase 1/2 × Melanoma × vitespin × Clear all

NCT02452281 2016-01-25

Pilot Study to Evaluate the Effects of a Vaccine (HSPPC-96) Combined With Ipilimumab in Patients With Advanced Melanoma

Phase 1/2 Withdrawn

Melanoma